Spots Global Cancer Trial Database for Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma
Official Title: Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma
Study ID: NCT03964298
Conditions
Interventions
Study Description
Brief Summary: Study of the activity of PD-1 inhibitors in metastatic uveal melanoma
Detailed Description: The aim of the research is to study the activity of PD-1 inhibitors in patients with metastatic uveal melanoma and treated by Nivolumab and Pembrolizumab. These molecules have already received the authorities approvals. The data collected will be crucial for the understanding of the mechanism of PD-1 inhibitors and also for the futures studies.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Rodrigues, Paris, Ile-de-France, France
Contact Details
Name: Manuel Rodrigues, MD
Affiliation: Institut Curie
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
